Convergent evidence for the antiviral effects of several FDA-approved phenothiazine antipsychotics against SARS-CoV-2 and other coronaviruses
Rodrigo Machado-Vieira1,2
, João Quevedo2,3,4,5
, Lokesh Shahani2
, Jair C. Soares1,2,4
DOI: 10.1590/1516-4446-2020-0024
Epub: 7 de Janeiro de 2021
Vol.43 Issue 5/2021: